WO2010026116A1 - Therapeutic light source - Google Patents

Therapeutic light source Download PDF

Info

Publication number
WO2010026116A1
WO2010026116A1 PCT/EP2009/061174 EP2009061174W WO2010026116A1 WO 2010026116 A1 WO2010026116 A1 WO 2010026116A1 EP 2009061174 W EP2009061174 W EP 2009061174W WO 2010026116 A1 WO2010026116 A1 WO 2010026116A1
Authority
WO
WIPO (PCT)
Prior art keywords
light source
laser diodes
wavelength
source according
pulses
Prior art date
Application number
PCT/EP2009/061174
Other languages
French (fr)
Inventor
Alexey Lukovkin
Alexander Ovchinnikov
Honsue Cho
Matt Murphy
Original Assignee
Photonics Appliance Solutions Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photonics Appliance Solutions Limited filed Critical Photonics Appliance Solutions Limited
Priority to AU2009289311A priority Critical patent/AU2009289311A1/en
Priority to CN2009901004464U priority patent/CN202263304U/en
Publication of WO2010026116A1 publication Critical patent/WO2010026116A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/062Photodynamic therapy, i.e. excitation of an agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0601Apparatus for use inside the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/067Radiation therapy using light using laser light
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/063Radiation therapy using light comprising light transmitting means, e.g. optical fibres
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/065Light sources therefor
    • A61N2005/0651Diodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/065Light sources therefor
    • A61N2005/0651Diodes
    • A61N2005/0652Arrays of diodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0658Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0659Radiation therapy using light characterised by the wavelength of light used infrared
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0658Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662Visible light

Definitions

  • the present invention relates to a therapeutic light source.
  • Photochemotherapy of cancer is often referred to as photodynamic therapy (PDT).
  • PDT photodynamic therapy
  • a photosensitizing agent is administered to a patient and is preferentially retained in tumour cells.
  • the agent is irradiated with visible or near infrared light, the wavelength of which is chosen to match the absorption wavelength of the photosensitizing agent.
  • the agent becomes excited and passes its energy to oxygen molecules within the cell to generate singlet oxygen and so cause cell necrosis.
  • the present invention seeks to provide an improved therapeutic light source.
  • a therapeutic light source comprising at least two laser diodes, means for causing the laser diodes to emit pulses of light substantially simultaneously and having intervals between pulses of less than 1 microsecond and means for coupling light emitted by the laser diodes into an optical fibre.
  • the light source can generate short pulses of light at high power which can be particular effective in therapies, such as PDT.
  • the therapeutic light source may comprise at least three laser diodes.
  • the therapeutic light source may comprise a first laser diode for emitting light at a first wavelength, a second laser diode for emitting light at a second wavelength and a third laser diode for emitting light at a third wavelength, wherein the first, second and third wavelengths are different.
  • the therapeutic light source may comprise at least two diodes for emitting light at the first wavelength, at least two diodes for emitting light at the second wavelength; and at least two diodes for emitting light at the third wavelength.
  • the first wavelength may be about 635 nm
  • the second wavelength may be about 1050 nm
  • the third wavelength may be about 1270 nm.
  • the laser diodes may be configured to output light having a combined power of at least 500 mW.
  • the combined power may be at least 1 W.
  • the means for causing the laser diodes to emit pulses of light may comprise means for generating a pulse waveform and means for driving current through the laser diodes, wherein the generating means provides at least one pulse waveform to the current driving means.
  • the therapeutic light source may comprises at least two current driving means, each configured to drive a respective laser diode; wherein the generating means provides at least two pulse waveforms.
  • the pulse waveform generating means may be a processor and the current driving means comprises an amplifier circuit.
  • the current driving means may include a means for switching current on and off and means for regulating current through a laser diode
  • the means for causing the laser diodes to emit pulses of light may be configured to cause the laser diodes to emit pulses having intervals between pulses of less than or equal to 100 ns or less than or equal to 10 ns.
  • At least two laser diodes a circuit arranged to cause the laser diodes to emit pulses of light substantially simultaneously and having intervals between pulses of less than 1 microsecond and a coupler for channelling light emitted by the laser diodes into an optical fibre.
  • the circuit may be programmable.
  • Figure 1 is schematic block diagram of a therapeutic light source in accordance with the present invention
  • Figure 2 is a timing diagram illustrating simultaneous output of pulsed light from laser diodes
  • Figure 3 is a more detailed view of some of the blocks shown in Figure 1 ; and Figure 4 illustrates in more detail a driver circuit shown in Figure 1.
  • a light source 1 for use in therapy such as PDT, in accordance with the present invention is shown.
  • the power output of the light source 1 can exceed 500 mW and operate in pulse mode producing pulses of light having pulse intervals and/or pulse duration less than 1 microsecond.
  • pulses of light at such high power can stimulate singlet oxygen production in tumour cells more efficiently.
  • the light source 1 includes a microprocessor 2 which provides a programmable signal generator 3.
  • the microprocessor 2 is coupled to circuits 4 (or “drivers") for driving respective semiconductor laser diodes 5.
  • the microprocessor 2 and the drivers 4 are supported on a motherboard (not shown).
  • the laser diodes 5 There may be two or more laser diodes 5. For example, there may be up to about 20 laser diodes. Some or all of the laser diodes 5 may emit light at the same wavelength. In this and some embodiments of the invention, the laser diodes 5 include at least two sets of laser diodes, preferably three sets of diodes, each set of laser diodes 5 emitting light at a different wavelength. A set of laser diodes 5 may include one or more than one laser diode.
  • the laser diodes 5 include a first set of diodes 5j which emit light at a first wavelength X 1 , in this case 635 nm, a second set of laser diodes 5 2 which emit light at a second, different wavelength X 2 (X 2 ⁇ X 1 ), in this example 1050 nm, and a third set of laser diodes 5 3 which emit light at a third, different wavelength ⁇ 3 ( ⁇ 3 ⁇ X 2 ⁇ X 1 ), in this case 1270 nm.
  • Suitable laser diodes 5 can be obtained from LDX Optronics, Inc., 1729 Triangle Park Drive, Maryville, TN 37801, USA.
  • the laser diodes 5 form part of an optical system 6.
  • the laser diodes 5 are attached via respective optical fibres 7 to an optical junction 8 (or "node” or “coupler") which is attached to one end of an optical fibre 9 having a diameter, in this example, of about 200 to 400 ⁇ m.
  • the optical junction 8 focuses light into the fibre 9.
  • the optical junction 8 includes a dense, polished semicylindrical prism (not shown) and a gradient lens (not shown) which gathers scattered photons and focuses them into the optical fibre 7.
  • the light source 1 is housed in a casing (not shown).
  • the light source 1 is cheap to produce, compared with conventional dedicated high-power lasers since laser diodes 5 are inexpensive.
  • the laser diodes 5 are mounted and rigidly fixed onto the motherboard (not shown) which includes a cooling system (not shown) comprising fans and/or heat sinks.
  • the light source 1 also includes a power supply unit 11, control panel 12, display 13 and memory 14.
  • control panel 12 and display 13 are combined in the form of a touch screen display.
  • the control panel 12 includes actuators, e.g. push buttons, switches or selectable regions on a touch display, for switching power on and off, starting and stopping light output, setting output power, resetting, switching between pulse and continuous modes, setting the duration of flashes and/or pauses and setting the brightness of an aiming beam.
  • Power output can be selected, for example, in a range 100 mW to 1 W, in increments of 100 mW. If multiple wavelengths are used, the control panel 12 may include an actuator for switching between wavelengths.
  • the display 13 indicates operation and other settings, such as whether power is one or off, output power (W), pulse/continuous mode, indicator 'ready', flash duration (in nanoseconds), duration of pause (in nanoseconds) and flash counter.
  • the total output power of the laser diodes is about IW.
  • the total power can be lower or higher.
  • the light source 1 can be operated in continuous or pulse mode.
  • the light source 1 in pulse mode, can generate pulses of light having duration, T w , of the order of 1 or 10 nanoseconds, e.g. about 5 - 10 nanoseconds, and/or separated by intervals, T 1 , of the order of 1 or 10 nanoseconds, e.g. about 5 - 10 nanoseconds.
  • T w duration of 1 or 10 nanoseconds
  • T 1 intervals of the order of 1 or 10 nanoseconds
  • the laser diodes 5 are arranged to emit pulses of light substantially simultaneously. However, the laser diodes 5 can work with a delay.
  • microprocessor 2 and drivers 4 can be used instead of a conventional (dedicated) high-frequency driver which is complex and costly. This can help reduce power consumption and heat production.
  • the light source 1 can also be used as part of an integrated unit (or "array") (not shown).
  • the array (not shown) includes the light source 1 and a fluoroscopy camera (not shown) for monitoring the quantity of singlet oxygen produced during therapy (usually referred to as the "yield of singlet oxygen").
  • the life time of singlet oxygen is short and usually lasts no more than 50 nanoseconds.
  • circuitry 15 of the light source 1 shown in more detail.
  • the microprocessor 2 is operatively connected to the drivers 4 using digital-to- analogue converters (DACs) 16 l 5 16 2 , 16 3 .
  • DACs digital-to- analogue converters
  • the digital-to-analogue converters 1O 1 , 16 2 , 16 3 may be provided internally by the microprocessor 2 and/or externally as separate units.
  • the microprocessor 2 can provide signals to an external digital-to-analogue converter via a bus 17, such as Inter-Integrated Circuit (I2C) bus having serial data (SDA) and serial clock (SCL) lines 17 l 5 17 2 .
  • I2C Inter-Integrated Circuit
  • SDA serial data
  • SCL serial clock
  • the microprocessor 2 is provided with RAM 14 ⁇ and with flash memory 14 2 for storing BIOS and control software.
  • a foot-operated treadle 18 can also be used to control operation of the light source 1.
  • the microprocessor 2 generates a programmable waveform using its internal clock (not shown).
  • the driver 4 is configured to drive the laser diode 5 using a constant current source.
  • the laser diode 4 is connected in series between positive supply 19 and ground 20 via a Darlington transistor 21, power field-effect transistor 22 and sensing resistance 23.
  • a signal from the DAC 16 is fed into a first input 24 of a differential amplifier 25.
  • the first input 24 is a non-inverting input.
  • the output 26 of the differential amplifier 25 is connected to a first resistor 27 (in this example, R 1 is about 2k ⁇ ) which in turn is connected to the base 28 of the Darlington transistor 21.
  • the laser diode 5 is connected between the supply 19 and the collector 29 of the Darlington transistor 21.
  • the emitter 30 of the Darlington transistor 21 is connected to the drain 31 of the power field-effect transistor 22.
  • the differential amplifier 25 is arranged to provide full gain swing between the supply rails.
  • a signal from the DAC 16 provides control (e.g. 'high' and 'low' signal) for switching the diode 5 on and off.
  • the differential amplifier 25 provides a high gain signal for switching the Darlington transistor 21 on and off, which in turn switches the laser diode 5 on and off.
  • the sensing point 33 is connected to a second resistor 35 (in this example, R 2 is about 10 k ⁇ ) which is connected in series to a first variable resistor 36 (in this example, R ⁇ 1 is about 10 k ⁇ ) which in turn is connected to ground 37 thereby forming a potential divider.
  • a tapping point 38 (also often refereed to as a "wiper") of the first variable resistor 36 is connected into a first input 39 of the voltage comparator 32.
  • the first input 39 is a non-inverting input.
  • a reference voltage is applied to a second input 40 of the voltage comparator 32.
  • the output 41 of the voltage comparator 32 is fed back to the first input 39 of the voltage comparator 32 via third resistor 42 (in this example, R 3 is about 1 M ⁇ ).
  • the output 41 is also connected to the gate 43 of the power field-effect transistor 22.
  • the gate 43 is also connected to positive supply 44 via a fourth resistor 45 (in this example, R 4 is about 4.7k ⁇ ).
  • the reference voltage is provided using a positive voltage 46 (e.g. +5V), regulated by a fifth resistor 47 (in this example, R 5 is about 510 ⁇ ) and a Zener diode 48, and set using a sixth resistor 49 (in this example, R 6 is about 10 k ⁇ ), a second variable resistor 50 and first capacitor 51 (in this example, C 1 is about 0.1 ⁇ F).
  • the sixth resistor 49 is arranged in series with a parallel arrangement of the second variable resistor 50 (in this example, R ⁇ 2 is about 10 k ⁇ ) and first capacitor 51. However, one terminal 52 of the first capacitor 51 is connected to both an end terminal 53 and a tapping terminal 54 of the second variable resistor 50.
  • the sensing node 33 is also connected to a second capacitor 55 (in this example, C 2 is about 0.1 (IF) which is connected to ground 56.
  • the sensing node 33 is also connected to a seventh resistor 57 (in this example, R 6 is about 10 k ⁇ ) which is connected to a first end terminal 58 and a tap terminal 59 of a third variable resistor 60 (in this example, R v3 is about 15 k ⁇ ).
  • a second end terminal 61 of the third variable resistor 60 is connected to a second input 62 of the differential amplifier 25 and to an eighth resistor 63 (in this example, R 8 is about 10 k ⁇ ) which, in turn, is connected to ground 64.
  • the first input 24 of the differential amplifier 25 is connected to the DAC 16 ( Figure 3) and also to a ninth resistor 65 (in this example, R 9 is about 10 k ⁇ ) connected to ground 66.
  • the sensing resistance 23 is formed by a parallel arrangement of tenth and eleventh resistors 67, 68 (in this example, R 10 is about 3.9 ⁇ and R n is about 0.56 ⁇ ).
  • the differential amplifier 25 is an AD 626 (Analogue Devices)
  • the Darlington transistor 21 is a KT 829
  • the voltage comparator32 is an LM211 (National Semiconductor)
  • the Zener diode is KC 107
  • the power field-effect transistor is an IRFZ44N (International Rectifier).
  • Other components having similar parameters may be used. Values of resistances and capacitances may vary.
  • the driver 4 illustrated in Figure 4 can allow the laser diode 5 to be switched quickly, e.g. having pulse durations and/or pulse widths of the order of 1, 10 or 100 ns, while also delivering high currents, e.g. currents of the order of IA.
  • the microcontroller 2 ( Figure 3) can select which drivers 4 to use, thereby selecting wavelength and power.
  • the microcontroller 2 supplies the same waveform or synchronised waveforms to the selected drivers 4, thereby allowing high power pulses of light to be generated.

Abstract

A therapeutic light source comprising at least two laser diodes (51, 52, 53), means (2, 4) for causing the laser diodes to emit pulses of light substantially simultaneously and having intervals between pulses of less than 1 microsecond and means (8) for coupling light emitted by the laser diodes into an optical fibre.

Description

Therapeutic light source
Description
The present invention relates to a therapeutic light source.
Photochemotherapy of cancer is often referred to as photodynamic therapy (PDT). In PDT, a photosensitizing agent is administered to a patient and is preferentially retained in tumour cells. The agent is irradiated with visible or near infrared light, the wavelength of which is chosen to match the absorption wavelength of the photosensitizing agent. The agent becomes excited and passes its energy to oxygen molecules within the cell to generate singlet oxygen and so cause cell necrosis.
The present invention seeks to provide an improved therapeutic light source.
According to the present invention there is provided a therapeutic light source comprising at least two laser diodes, means for causing the laser diodes to emit pulses of light substantially simultaneously and having intervals between pulses of less than 1 microsecond and means for coupling light emitted by the laser diodes into an optical fibre.
Thus, the light source can generate short pulses of light at high power which can be particular effective in therapies, such as PDT.
The therapeutic light source may comprise at least three laser diodes.
The therapeutic light source may comprise a first laser diode for emitting light at a first wavelength, a second laser diode for emitting light at a second wavelength and a third laser diode for emitting light at a third wavelength, wherein the first, second and third wavelengths are different.
The therapeutic light source may comprise at least two diodes for emitting light at the first wavelength, at least two diodes for emitting light at the second wavelength; and at least two diodes for emitting light at the third wavelength. The first wavelength may be about 635 nm, the second wavelength may be about 1050 nm and the third wavelength may be about 1270 nm.
The laser diodes may be configured to output light having a combined power of at least 500 mW. The combined power may be at least 1 W.
The means for causing the laser diodes to emit pulses of light may comprise means for generating a pulse waveform and means for driving current through the laser diodes, wherein the generating means provides at least one pulse waveform to the current driving means.
The therapeutic light source may comprises at least two current driving means, each configured to drive a respective laser diode; wherein the generating means provides at least two pulse waveforms.
The pulse waveform generating means may be a processor and the current driving means comprises an amplifier circuit. The current driving means may include a means for switching current on and off and means for regulating current through a laser diode
The means for causing the laser diodes to emit pulses of light may be configured to cause the laser diodes to emit pulses having intervals between pulses of less than or equal to 100 ns or less than or equal to 10 ns.
According to the present invention there is provided at least two laser diodes, a circuit arranged to cause the laser diodes to emit pulses of light substantially simultaneously and having intervals between pulses of less than 1 microsecond and a coupler for channelling light emitted by the laser diodes into an optical fibre.
The circuit may be programmable. Embodiments of the present invention will now be described, by way of example, with reference to the accompanying drawings in which:
Figure 1 is schematic block diagram of a therapeutic light source in accordance with the present invention; Figure 2 is a timing diagram illustrating simultaneous output of pulsed light from laser diodes;
Figure 3 is a more detailed view of some of the blocks shown in Figure 1 ; and Figure 4 illustrates in more detail a driver circuit shown in Figure 1.
Referring to Figure 1, a light source 1 for use in therapy, such as PDT, in accordance with the present invention is shown. As will be explained in more detail later, the power output of the light source 1 can exceed 500 mW and operate in pulse mode producing pulses of light having pulse intervals and/or pulse duration less than 1 microsecond. When used in PDT, such pulses of light at such high power can stimulate singlet oxygen production in tumour cells more efficiently.
The light source 1 includes a microprocessor 2 which provides a programmable signal generator 3. The microprocessor 2 is coupled to circuits 4 (or "drivers") for driving respective semiconductor laser diodes 5. In this example, the microprocessor 2 and the drivers 4 are supported on a motherboard (not shown).
There may be two or more laser diodes 5. For example, there may be up to about 20 laser diodes. Some or all of the laser diodes 5 may emit light at the same wavelength. In this and some embodiments of the invention, the laser diodes 5 include at least two sets of laser diodes, preferably three sets of diodes, each set of laser diodes 5 emitting light at a different wavelength. A set of laser diodes 5 may include one or more than one laser diode.
In this and some embodiments of the invention, the laser diodes 5 include a first set of diodes 5j which emit light at a first wavelength X1, in this case 635 nm, a second set of laser diodes 52 which emit light at a second, different wavelength X2 (X2 φ X1), in this example 1050 nm, and a third set of laser diodes 53 which emit light at a third, different wavelength λ33 φ X2 φ X1), in this case 1270 nm. The wavelengths - A -
can be chosen to match the absorption wavelength or wavelengths of a particular photosensitizing agent and may be chosen, for example, from visible or near infrared wavelengths. Usually for PDT, the wavelength(s) is chosen to excite an activated molecule into a triplet state, which produces singlet oxygen. Suitable laser diodes 5 can be obtained from LDX Optronics, Inc., 1729 Triangle Park Drive, Maryville, TN 37801, USA.
The laser diodes 5 form part of an optical system 6. The laser diodes 5 are attached via respective optical fibres 7 to an optical junction 8 (or "node" or "coupler") which is attached to one end of an optical fibre 9 having a diameter, in this example, of about 200 to 400μm. The optical junction 8 focuses light into the fibre 9.
The optical junction 8 includes a dense, polished semicylindrical prism (not shown) and a gradient lens (not shown) which gathers scattered photons and focuses them into the optical fibre 7. The light source 1 is housed in a casing (not shown).
By combining light from more than one laser diode 5 using the optical junction 8, high power densities can be achieved. Furthermore, the light source 1 is cheap to produce, compared with conventional dedicated high-power lasers since laser diodes 5 are inexpensive.
The laser diodes 5 are mounted and rigidly fixed onto the motherboard (not shown) which includes a cooling system (not shown) comprising fans and/or heat sinks.
As shown in Figure 1, the light source 1 also includes a power supply unit 11, control panel 12, display 13 and memory 14.
In some embodiments, the control panel 12 and display 13 are combined in the form of a touch screen display.
The control panel 12 includes actuators, e.g. push buttons, switches or selectable regions on a touch display, for switching power on and off, starting and stopping light output, setting output power, resetting, switching between pulse and continuous modes, setting the duration of flashes and/or pauses and setting the brightness of an aiming beam. Power output can be selected, for example, in a range 100 mW to 1 W, in increments of 100 mW. If multiple wavelengths are used, the control panel 12 may include an actuator for switching between wavelengths.
The display 13 indicates operation and other settings, such as whether power is one or off, output power (W), pulse/continuous mode, indicator 'ready', flash duration (in nanoseconds), duration of pause (in nanoseconds) and flash counter.
In this example, there are six laser diodes 5 and the total output power of the laser diodes is about IW. However, depending on the power of each laser diode 5 and the number of laser diodes, the total power can be lower or higher.
The light source 1 can be operated in continuous or pulse mode.
Referring also to Figure 2, in pulse mode, the light source 1 can generate pulses of light having duration, Tw, of the order of 1 or 10 nanoseconds, e.g. about 5 - 10 nanoseconds, and/or separated by intervals, T1, of the order of 1 or 10 nanoseconds, e.g. about 5 - 10 nanoseconds. Thus, the light source 1 is beneficial for PDT and convenient for use with biological systems.
In pulse mode, the laser diodes 5 are arranged to emit pulses of light substantially simultaneously. However, the laser diodes 5 can work with a delay.
As will be explained in more detail later, the microprocessor 2 and drivers 4 can be used instead of a conventional (dedicated) high-frequency driver which is complex and costly. This can help reduce power consumption and heat production.
The light source 1 can also be used as part of an integrated unit (or "array") (not shown). The array (not shown) includes the light source 1 and a fluoroscopy camera (not shown) for monitoring the quantity of singlet oxygen produced during therapy (usually referred to as the "yield of singlet oxygen"). The life time of singlet oxygen is short and usually lasts no more than 50 nanoseconds. Referring to Figure 3, circuitry 15 of the light source 1 shown in more detail.
The microprocessor 2 is operatively connected to the drivers 4 using digital-to- analogue converters (DACs) 16l 5 162, 163.
As shown in Figure 3, the digital-to-analogue converters 1O1, 162, 163 may be provided internally by the microprocessor 2 and/or externally as separate units. The microprocessor 2 can provide signals to an external digital-to-analogue converter via a bus 17, such as Inter-Integrated Circuit (I2C) bus having serial data (SDA) and serial clock (SCL) lines 17l 5 172. The bus 17 can be used to control more than one digital-to-analogue converter.
The microprocessor 2 is provided with RAM 14α and with flash memory 142 for storing BIOS and control software. A foot-operated treadle 18 can also be used to control operation of the light source 1.
The microprocessor 2 generates a programmable waveform using its internal clock (not shown).
Referring to Figure 4, the circuitry of a driver 4 is shown in more detail.
The driver 4 is configured to drive the laser diode 5 using a constant current source.
The laser diode 4 is connected in series between positive supply 19 and ground 20 via a Darlington transistor 21, power field-effect transistor 22 and sensing resistance 23.
A signal from the DAC 16 is fed into a first input 24 of a differential amplifier 25. In this example, the first input 24 is a non-inverting input. The output 26 of the differential amplifier 25 is connected to a first resistor 27 (in this example, R1 is about 2kΩ) which in turn is connected to the base 28 of the Darlington transistor 21. The laser diode 5 is connected between the supply 19 and the collector 29 of the Darlington transistor 21. The emitter 30 of the Darlington transistor 21 is connected to the drain 31 of the power field-effect transistor 22. In this example, the differential amplifier 25 is arranged to provide full gain swing between the supply rails.
Thus, a signal from the DAC 16 provides control (e.g. 'high' and 'low' signal) for switching the diode 5 on and off. The differential amplifier 25 provides a high gain signal for switching the Darlington transistor 21 on and off, which in turn switches the laser diode 5 on and off.
Current through the laser diode 5 is regulated by the power field-effect transistor 22 which is controlled by a voltage comparator 32 which compares the voltage across the sensing resistance 23 taken at a sensing point 33 between the source 34 of the power field-effect transistor 22 and the sensing resistance 23.
The sensing point 33 is connected to a second resistor 35 (in this example, R2 is about 10 kΩ) which is connected in series to a first variable resistor 36 (in this example, R^1 is about 10 kΩ) which in turn is connected to ground 37 thereby forming a potential divider. A tapping point 38 (also often refereed to as a "wiper") of the first variable resistor 36 is connected into a first input 39 of the voltage comparator 32. In this example, the first input 39 is a non-inverting input. A reference voltage is applied to a second input 40 of the voltage comparator 32. The output 41 of the voltage comparator 32 is fed back to the first input 39 of the voltage comparator 32 via third resistor 42 (in this example, R3 is about 1 MΩ). The output 41 is also connected to the gate 43 of the power field-effect transistor 22. The gate 43 is also connected to positive supply 44 via a fourth resistor 45 (in this example, R4 is about 4.7kΩ).
The reference voltage is provided using a positive voltage 46 (e.g. +5V), regulated by a fifth resistor 47 (in this example, R5 is about 510 Ω) and a Zener diode 48, and set using a sixth resistor 49 (in this example, R6 is about 10 kΩ), a second variable resistor 50 and first capacitor 51 (in this example, C1 is about 0.1 μF). The sixth resistor 49 is arranged in series with a parallel arrangement of the second variable resistor 50 (in this example, R^2 is about 10 kΩ) and first capacitor 51. However, one terminal 52 of the first capacitor 51 is connected to both an end terminal 53 and a tapping terminal 54 of the second variable resistor 50.
The sensing node 33 is also connected to a second capacitor 55 (in this example, C2 is about 0.1 (IF) which is connected to ground 56. The sensing node 33 is also connected to a seventh resistor 57 (in this example, R6 is about 10 kΩ) which is connected to a first end terminal 58 and a tap terminal 59 of a third variable resistor 60 (in this example, Rv3 is about 15 kΩ). A second end terminal 61 of the third variable resistor 60 is connected to a second input 62 of the differential amplifier 25 and to an eighth resistor 63 (in this example, R8 is about 10 kΩ) which, in turn, is connected to ground 64. The first input 24 of the differential amplifier 25 is connected to the DAC 16 (Figure 3) and also to a ninth resistor 65 (in this example, R9 is about 10 kΩ) connected to ground 66.
In this example, the sensing resistance 23 is formed by a parallel arrangement of tenth and eleventh resistors 67, 68 (in this example, R10 is about 3.9 Ω and Rn is about 0.56 Ω).
In this and some embodiments of the invention, the differential amplifier 25 is an AD 626 (Analogue Devices), the Darlington transistor 21 is a KT 829, the voltage comparator32is an LM211 (National Semiconductor), the Zener diode is KC 107, and the power field-effect transistor is an IRFZ44N (International Rectifier). Other components having similar parameters may be used. Values of resistances and capacitances may vary.
The driver 4 illustrated in Figure 4 can allow the laser diode 5 to be switched quickly, e.g. having pulse durations and/or pulse widths of the order of 1, 10 or 100 ns, while also delivering high currents, e.g. currents of the order of IA.
The microcontroller 2 (Figure 3) can select which drivers 4 to use, thereby selecting wavelength and power. The microcontroller 2 supplies the same waveform or synchronised waveforms to the selected drivers 4, thereby allowing high power pulses of light to be generated.
It will be understood that the present invention has been described above by way of example only. For example, it will be appreciated that an alternative control circuit, for example using a different configuration, may be used instead of the control circuit including the differential amplifier 19 and the Darlington pair 21. Similarly, it will be appreciated that an alternative current regulation circuit, for example, using a different configuration, may be used instead of the current regulation circuit including the power transistor 22 and voltage comparator 32. The examples are not intended to limit the scope of the invention. Various modifications and embodiments can be made without departing from the scope and spirit of the invention, which is defined by the following claims only.

Claims

Claims
1. A therapeutic light source comprising: at least two laser diodes; means for causing the laser diodes to emit pulses of light substantially simultaneously and having intervals between pulses of less than 1 microsecond; and means for coupling light emitted by the laser diodes into an optical fibre.
2. A therapeutic light source according to claim 1, comprising: at least three laser diodes.
3. A therapeutic light source according to claim 2, including: a first laser diode for emitting light at a first wavelength; a second laser diode for emitting light at a second wavelength; and a third laser diode for emitting light at a third wavelength; wherein the first, second and third wavelengths are different.
4. A therapeutic light source according to claim 3, comprising: at least two diodes for emitting light at the first wavelength; at least two diodes for emitting light at the second wavelength; and at least two diodes for emitting light at the third wavelength.
5. A therapeutic light source according to claim 3 or 4, wherein the first wavelength is about 635 nm, the second wavelength is about 1050 nm and the third wavelength is about 1270 nm.
6. A therapeutic light source according to any preceding claim, wherein the laser diodes are configured to output light having a combined power of at least 500 mW.
7. A therapeutic light source according to claim 6, wherein the combined power is at least 1 W.
8. A therapeutic light source according to any preceding claim, wherein the means for causing the laser diodes to emit pulses of light comprises: means for generating a pulse waveform; and means for driving current through the laser diodes, wherein the generating means provides at least one pulse waveform to the current driving means.
9. A therapeutic light source according to claim 8, comprising: at least two current driving means, each configured to drive a respective laser diode; wherein the generating means provides at least two pulse waveforms.
10. A therapeutic light source according to claim 8 or 9, wherein: the pulse waveform means is a processor; and the current driving means comprises an amplifier circuit.
11. A therapeutic light source according to any one of claims 8 to 10, wherein the current driving means includes a means for switching current on and off and means for regulating current through a laser diode.
12. A therapeutic light source according to any preceding claim, wherein the means for causing the laser diodes to emit pulses of light is configured to cause the laser diodes to emit pulses having intervals between pulses of less than or equal to 100 ns.
13. A therapeutic light source according to any preceding claim, wherein the means for causing the laser diodes to emit pulses of light is configured to cause the laser diodes to emit pulses having intervals between pulses of less than or equal to 10 ns.
14. A therapeutic light source comprising: at least two laser diodes; a circuit arranged to cause the laser diodes to emit pulses of light substantially simultaneously and having intervals between pulses of less than 1 microsecond; and a coupler for channelling light emitted by the laser diodes into an optical fibre.
15. A therapeutic light source according to claim 14, wherein the circuit is programmable.
PCT/EP2009/061174 2008-09-02 2009-08-28 Therapeutic light source WO2010026116A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2009289311A AU2009289311A1 (en) 2008-09-02 2009-08-28 Therapeutic light source
CN2009901004464U CN202263304U (en) 2008-09-02 2009-08-28 Optical therapeutic apparatus

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0815950A GB2463075A (en) 2008-09-02 2008-09-02 Therapeutic light source
GB0815950.1 2008-09-02

Publications (1)

Publication Number Publication Date
WO2010026116A1 true WO2010026116A1 (en) 2010-03-11

Family

ID=39866106

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/061174 WO2010026116A1 (en) 2008-09-02 2009-08-28 Therapeutic light source

Country Status (4)

Country Link
CN (1) CN202263304U (en)
AU (1) AU2009289311A1 (en)
GB (1) GB2463075A (en)
WO (1) WO2010026116A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030167080A1 (en) * 2002-03-04 2003-09-04 Hart Barry Michael Joint / tissue inflammation therapy and monitoring device(s) JITMon device
WO2003086215A1 (en) * 2002-04-11 2003-10-23 Light Bioscience, Inc. Low intensity light therapy for the manipulation of fibroblast-derived mammalian cells and collagen
US20060047336A1 (en) * 2004-08-25 2006-03-02 Gale David C Stent-catheter assembly with a releasable connection for stent retention
US20060212025A1 (en) * 1998-11-30 2006-09-21 Light Bioscience, Llc Method and apparatus for acne treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658323A (en) * 1995-07-12 1997-08-19 Miller; Iain D. Method and apparatus for dermatology treatment
US6385221B1 (en) * 1999-06-25 2002-05-07 Ceramoptec Industries, Inc. Multiplexed medical diode laser system
DE10108655A1 (en) * 2001-02-22 2002-09-26 W & H Dentalwerk Buermoos Ges Medical laser treatment device
US20050131499A1 (en) * 2001-03-02 2005-06-16 Shanks Steven C. Laser device to treat sympathetic and parasympathetic nervous systems
US7762965B2 (en) * 2001-12-10 2010-07-27 Candela Corporation Method and apparatus for vacuum-assisted light-based treatments of the skin
EP1627662B1 (en) * 2004-06-10 2011-03-02 Candela Corporation Apparatus for vacuum-assisted light-based treatments of the skin
AU2003292591A1 (en) * 2003-06-20 2005-01-04 Keio University Photodynamic therapy apparatus, method for controlling photodynamic therapy apparatus, and photodynamic therapy method
DE102006019127A1 (en) * 2006-04-25 2007-10-31 Carl Zeiss Meditec Ag Multi-wavelength laser system and method for ophthalmic applications

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060212025A1 (en) * 1998-11-30 2006-09-21 Light Bioscience, Llc Method and apparatus for acne treatment
US20030167080A1 (en) * 2002-03-04 2003-09-04 Hart Barry Michael Joint / tissue inflammation therapy and monitoring device(s) JITMon device
WO2003086215A1 (en) * 2002-04-11 2003-10-23 Light Bioscience, Inc. Low intensity light therapy for the manipulation of fibroblast-derived mammalian cells and collagen
US20060047336A1 (en) * 2004-08-25 2006-03-02 Gale David C Stent-catheter assembly with a releasable connection for stent retention

Also Published As

Publication number Publication date
CN202263304U (en) 2012-06-06
AU2009289311A1 (en) 2010-03-11
GB0815950D0 (en) 2008-10-08
GB2463075A (en) 2010-03-03

Similar Documents

Publication Publication Date Title
US7957440B2 (en) Dual pulse-width medical laser
US8575840B2 (en) Light source turn-on/off controller
CA1133348A (en) Device for the local treatment of a patient and more particularly applicable in acupuncture and auriculotherapy
US20170070029A1 (en) Optical pulse emitter
US20070106347A1 (en) Portable medical and cosmetic photon emission adjustment device and method using the same
US8970125B2 (en) UV irradiation apparatus
US20140214136A1 (en) Pulse Width Modulation Control for Battery-Powered Laser Device
US20140314112A1 (en) Bias Current Control Of Laser Diode Instrument To Reduce Power Consumption Of The Instrument
EP2556723B1 (en) Driver system for driving a plurality of leds
JP2007042731A (en) Pulse power supply device
US9282620B2 (en) Apparatus and method for generating constant current pulse wave, medical operation method using same, and light generating apparatus
US20230134679A1 (en) Managing optical power in laser system
ATE536804T1 (en) HIGH VOLTAGE GENERATING CIRCUIT, PUNCTURE DEVICE AND BLOOD TEST DEVICE
WO2010026116A1 (en) Therapeutic light source
JP2014531755A (en) LED driver
JP2013530763A (en) Spectral sweep type photocrosslinking device
US20220273399A1 (en) Systems combining therapeutic lasers and curing lights
KR101510846B1 (en) Apparatus for controling consumption of electrical power and method for controling the same
RU2687568C1 (en) Universal laser diode medical device
KR200225764Y1 (en) Integrated therapeutic device using a visible light and ultrasound
KR200302173Y1 (en) Electric matt using low power laser diodes with reliable and stable laser beam
WO2008105093A1 (en) Toning circuit for liquid crystal back light
JPH09225049A (en) Phototherapeutic apparatus with low-frequency therapy
JPH11151307A (en) Laser therapy device
CN216291510U (en) Pulse steady-state semiconductor light source

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200990100446.4

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09782365

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 592004

Country of ref document: NZ

Ref document number: 2009289311

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2009289311

Country of ref document: AU

Date of ref document: 20090828

Kind code of ref document: A

122 Ep: pct application non-entry in european phase

Ref document number: 09782365

Country of ref document: EP

Kind code of ref document: A1